Like most forms of cancer, brain cancers are frequently treated with chemotherapy and radiation therapy. Although these treatments can be effective, many times they are not. Scientists around the world study different types of brain cancers to develop new treatment methods.
Read MoreTags: CA, University of California San Diego, cancer research, SDVS, UCSD, Biotechnology Vendor Showcase Event, 2018, Zika virus, Brain cancer
UC Davis has a long history of ground breaking stem cell research. Possible therapies studied range from advanced wound healing, treating HIV, and reduced vision loss to the regeneration of bone in otherwise non-healing fractures. Now The California Institute for Regenerative Medicine (CIRM) has awarded UC Davis Medical Center scientists nearly $8 million in research funding to launch a special clinical trials program in Sacramento. The goal of the grant is to accelerate the development and delivery of stem cell therapies in human patients.
Read MoreTags: CA, Current Biotechnology Events, immunotherapy, Stem cell research, Human Stem Cell, California, Research Funding, laboratory equipment, research grant, laboratory equipment suppliers, UC Davis - Medical Center, Southwest Region, new research grant, UCD, Lab Supply, BioResearch Product Faire, Bioresearch Grant, Laboratory product sales, laboratory tools
Organ transplants are common surgeries that happen around the world. In the United States, more than 33,000 transplants occurred in 2016, with more than half of these being kidney transplants. Although the majority of people come out of transplant surgery with no problems, many develop serious infections caused by the common virus cytomegalovirus (CMV)when the immune system rejects the new kidney.
Read MoreTags: CA, new research funding, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, 2017, cytomegalovirus
According to the World Health Organization, more than 36.7 million people around the world are infected with Human Immunodeficiency Virus (HIV). Although there is not yet a cure for HIV, some treatments are able to slow the spread of the virus. Researchers around the world study the virus with the hope of one day creating a cure to attack the virus. A team of researchers from the University of Southern California in Los Angeles are taking a different approach to fighting HIV - by creating a treatment that boosts the immune system instead of attacking the virus.
Read MoreTags: CA, University of Southern California, USC, Los Angeles, BioResearch Product Faire Event, HIV research, 2018, HIV treatment
The University of California, Irvine is a growing life science research institution that is continually growing its research facilities and capabilities. A recent gift of $200 million dollars is the latest funding helping UCI establish itself as a leading life science research institution. (Image of the UCI Science Plaza by By David Eppstein via Wikimedia Commons)
Read MoreTags: CA, new research building, University of California Irvine, BioResearch Product Faire Event, UCI, 2017, College of Health Sciences, Integrative Health Research
UC Davis Medical Center’s Mind Institute was one of five institutes in the nation to win the NIH’s Autism Centers of Excellence Award (ACE). The $12 million, five year grant, will be used for the creation of the “Center for the Development of Phenotype-based Treatments of Autism Spectrum Disorder.” This new center will take a personalize approach to addressing autism spectrum disorder (ASD) treatment based on a child’s behavioral and biological characteristics. The goal will be to identify and tailor treatments that improve the quality of life for those with ASD.
Read MoreTags: CA, Current Biotechnology Events, California, NIH funded Research Projects, Autism, Research Funding, laboratory equipment, research grant, laboratory equipment suppliers, UC Davis - Medical Center, Southwest Region, new research grant, UCD, Lab Supply, drug evaluation, BioResearch Product Faire, autism research, Bioresearch Grant, Laboratory product sales, NIH awards 2017
Next week PLOS journal will publish an exciting article featuring a new biological discovery. Scientists at UC Riverside have discovered critical information regarding insect development.
This study uncovers the use of DNA as an organism’s biological clock in sexual development, or metamorphosis in insects. With applications in new cancer treatments, agriculture, human health and potential applications in zoology, this study opens gateways of undiscovered information. This is one exciting example of the potential in research and the intersectionality in life science, molecular biology and biotechnology supplies.
Read More
Tags: CA, agriculture, DNA Research, Cancer, Genome, UCR, Fruit Fly
Currently, there are no FDA approved medications for treating fragile X syndrome. That may soon change, thanks to a $11.5 million NIH grant awarded to UC Davis Medical Center. The new funding will allow researchers to test a new drug that is designed to improve language learning for children with fragile X syndrome. UC Davis is one of only two medical centers approved for the drug trail in the nation. Since UC Davis Medical Center is home to the renowned MIND Institute, which hosts the Fragile X Research and Treatment Center, it is a logical choice for the treatment study.
Read MoreTags: CA, California, Research Funding, Drug Development, research grant, UC Davis - Medical Center, Southwest Region, new research grant, UCD, drug evaluation, BioResearch Product Faire, Bioresearch Grant
USC recently opened the USC Stevens Hall for Neuroimaging, the new home for the Mark and Mary Stevens Neuroimaging and Informatics Institute. The sleek, modern, state-of-the-art research building is located on the southern edge of USC's Health Sciences Campus and will help accelerate research on neurologic disorders such as autism and Alzheimer’s Disease.
Read MoreTags: CA, University of Southern California, new research building, New research facilities, California, USC, Southwest Region, New research center
Researchers at University of California San Diego School of Medicine were recently awarded two Type 1 Diabetes Special Statutory Funding Program grants from the NIH, totaling more than $5 million in research funding.
Read MoreTags: CA, University of California San Diego, Diabetes, California, University of California, UCSD, Research Funding, UC San Diego, new research grants, NIH award, Southwest Region, research grants, Type 1 Diabetes, Diabetes research